|
RMND5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.622800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.821600E-01 |
| Normal-vs-Stage2 |
3.228600E-01 |
| Normal-vs-Stage3 |
1.249820E-02 |
| Normal-vs-Stage4 |
2.703800E-02 |
| Stage1-vs-Stage2 |
2.396200E-01 |
| Stage1-vs-Stage3 |
8.219800E-03 |
| Stage1-vs-Stage4 |
3.678200E-02 |
| Stage2-vs-Stage3 |
3.019100E-03 |
| Stage2-vs-Stage4 |
8.399300E-03 |
| Stage3-vs-Stage4 |
9.175800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.226560E-01 |
| Normal-vs-AfricanAmerican |
9.045400E-01 |
| Normal-vs-Asian |
2.413000E-01 |
| Caucasian-vs-AfricanAmerican |
3.216800E-01 |
| Caucasian-vs-Asian |
9.971400E-01 |
| AfricanAmerican-vs-Asian |
4.316400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.445000E-01 |
| Normal-vs-Female |
3.832000E-01 |
| Male-vs-Female |
9.955000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.686600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.597790E-01 |
| Normal-vs-Age(61-80Yrs) |
2.430000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.167700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.178360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.165600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.273170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.957600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.972600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.249400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.64659999991291E-07 |
| Classical-VS-Follicular |
1.511560E-01 |
| Classical-VS-Other |
7.490600E-01 |
| Classical-VS-Normal |
6.728800E-01 |
| Tall-VS-Follicular |
5.33180000039657E-07 |
| Tall-VS-Other |
4.878300E-02 |
| Tall-VS-Normal |
1.79907999999784E-05 |
| Follicular-VS-Other |
4.778000E-01 |
| Follicular-VS-Normal |
4.117000E-01 |
| Other-VS-Normal |
5.667200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.344000E-01 |
| Normal-vs-N1 |
5.261300E-03 |
| N0-vs-N1 |
3.522200E-03 |
|
|
